Sarda Proteins Board Meeting on Fundraising August 5

The primary agenda for the board meeting includes:

• Proposal for raising funds through issuance of various securities including equity shares, convertible bonds, debentures, convertible warrants, preference shares, or any other equity linked securities
• The fundraising may be conducted through permissible modes including rights issue, private placement, preferential issue, qualified institutions placement (QIP), or any other method permitted under applicable laws
• The company references compliance with the Companies Act, 2013 and Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018
• The board may also consider any other items with the permission of the chairperson

The disclosure was signed by Shirish Dhirajlal Savaliya, Managing Director (DIN: 08721554), on behalf of the Board of Directors of Sarda Proteins Limited.

Financial Impact

Financial impact not quantified in the disclosure. The meeting is to consider proposals for fundraising, but specific amounts, terms, or dilution percentages are not disclosed.